Condition: Advanced Heart Failure · Sponsor: CorWave
The study is a prospective, multi-center, non-randomized trial to evaluate the safety and effectiveness of the CorWave LVAS for the treatment of advanced heart failure patients.
This description comes directly from the study's public registry record.
Gabriella Giaquinta · +49 151 129 68474 · gabriella.giaquinta@corwave.com
Always discuss trial participation with your own doctor first.
| St Vincent's Hospital Sydney | Sydney, New South Wales, Australia | Recruiting |
| Bayside Health | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06907017